Alpha DNA Investment Management’s Carlisle Companies CSL Stock Holding History

Alpha DNA Investment Management’s Portfolio CSL Stock Details CSL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,841	Closed	-$796K	–	160
2022 Q3	$796K	Buy	+2,841	New	+$814K	0.66%	42
2021 Q1	–	Sell	-17	Closed	-$2K	–	706
2020 Q4	$2K	Buy	+17	New	+$2.39K	﹤0.01%	452

Other funds holding CSL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Alpha DNA Investment Management's CSL Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Carlisle Companies (CSL) in Q4 2022, closing a stake of 2,841 shares — an estimated $796K sold.

Alpha DNA Investment Management first reported a position in CSL in Q4 2020 and held it in 2 quarters. The position peaked at $796K in Q3 2022. 578 funds tracked by Wall St. Rank hold CSL as of Q4 2022.

Alpha DNA Investment Management reported no remaining Carlisle Companies position as of Q4 2022 after selling out during the quarter.
Alpha DNA Investment Management sold 2,841 Carlisle Companies shares in Q4 2022, an estimated $796K.
Alpha DNA Investment Management first reported a position in Carlisle Companies in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's Carlisle Companies position peaked at $796K in Q3 2022.
578 funds tracked by Wall St. Rank held Carlisle Companies as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.